Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules

NCT01073553 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Anti-Infective Agents

Interventions

DRUG: Cephalexin capsules (Optocef, BAYO5448 )
DRUG: Cephalexin capsules (Keflex)

Sponsor

Bayer

Collaborators

[object Object]